Dimenhydrinate Injection Shortage

• • Dimenhydrinate injection, Fresenius Kabi, 50 mg/mL, 1 mL vial, 25 count, NDC 63323-0366-01

• • Fresenius Kabi did not provide a reason for the shortage.
  • Fresenius Kabi is the sole supplier of dimenhydrinate injection.

• • There is insufficient supply for usual ordering

Estimated Resupply Dates

• • Fresenius Kabi has short-dated dimenhydrinate 50 mg/mL 1 mL vials available with an expiration date of < 4 months. The company estimates a release date of late-August 2025 for product with regular dating.